Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-06-01 · accession 0001209191-23-033675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-02 | 2023-06-01 | CBIO | Koenig Scott | Dir | M - OptEx | $0.6 | +21.0K | 36.8K | +133% | +$12.6K |
| D | 2023-06-02 | 2023-06-01 | CBIO | Koenig Scott | Dir | M - OptEx | $0.00 | -21.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | M | A | 21,000 | $0.6 | 36,750 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2023-06-01 | M | D | 21,000 | $0.00 | 0 | D | $0.6 · — to 2032-05-17 | 21,000 Common Stock | (F1) The shares underlying this option vested on May 18, 2023 and are fully exercisable. |